”Malariaprojekt kan öka motståndet mot vaccin”
October 28, 2021 | Forskning & Framsteg
Världshälsoorganisationen fattade nyligen ett historiskt beslut om att rekommendera ett ma...


The BRAAVE 2020 Study: Engaging Black American Communities In HIV Clinical Research
October 28, 2021 | Clinical Leader
By Omoro Omoighe, MPH, and Sean Collins, MD, MS, Gilead Sciences...


18th Annual STD & AIDS Research Symposium
October 28, 2021 | All Events Online
CLICK HERE: https://bit.ly/3m1ZKBI and you'll receive a personal Zoom link to attend. AB...


Paradoxical manifestations during tuberculous meningitis treatment among HIV-negative patients: a retrospective descriptive study and literature review - Neurological Sciences
October 27, 2021 | Springer
Abstract Background Tuberculous meningitis (TBM) is the most frequent, severe, and disabli...


Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV: A Qualitative Study - AIDS and Behavior
October 27, 2021 | Springer
Abstract The combined burden of geriatric conditions, comorbidities, and HIV requires a mo...


Trump visar sitt stöd för Bolsonaro: ”Goda vänner”
October 27, 2021 | DN.se
RIO DE JANEIRO. USA:s före detta president Donald Trump visar sitt stöd till Brasiliens Bo...


Asia Pacific HIV Diagnostics Market Share, Size, 2021 Industry Research Report 2027 | By -Abbott Laboratories, Merck Kgaa, F. Hoffmann-La Roche Ag, Atomo Diagnostics, Siemens Healthineers Inc
October 27, 2021 | MarketWatch
Asia Pacific HIV Diagnostics Market 2021 Overview, CAGR, Production Volume, Sales, Revenue...


New study to assess potency of six monthly injection for HIV prevention
October 27, 2021 | The Independent
Kampala, Uganda | THE INDEPENDENT | Researchers will in December enroll the first particip...


New Study Assesses Potency of Six Monthly Injection for HIV Prevention
October 27, 2021 | Uganda Radio Network
This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala for...


Merck & Co Inc Merck Presents New Data from Ongoing Phase 2b Clinical Trial Evaluating Efficacy and Safety of Investigational Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 Treatment at EACS 2021 (Businesswire)
October 27, 2021 | Avanza Bank
Merck & Co Inc Merck Presents New Data f...